Menveo Market Report 2026
Download Free Sample Buy Now
Menveo Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Menveo Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Menveo Market Overview

• The Menveo market growth in the historic period has been driven by expansion of national immunization schedules, historical outbreaks of meningococcal disease

• Market expansion is supported by growing investments in vaccine innovation, rising focus on outbreak prevention

• Growth Driver: Increase In Meningitis Cases Fueling Demand For Menveo Vaccine

• Market Trend: Innovative Vaccine Formulations Driving Market Trends

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Menveo Market?

Menveo is a meningococcal vaccine that protects against infections caused by Neisseria meningitidis. It targets serogroups A, C, W, and Y, which can cause meningitis and bloodstream infections. The vaccine is recommended for adolescents, young adults, and individuals at higher risk of meningococcal disease.

The main vaccine types of menveo are conjugate vaccine and combination vaccine. A conjugate vaccine combines a bacterial protein with a polysaccharide (sugar molecule) to enhance the immune response. This combination helps the immune system recognize and attack the bacteria more effectively. It is indicated for various purposes, including meningococcal disease prevention, routine immunization, outbreak control, and travel vaccination. Menveo is used for different age groups, including infants and young children, adolescents, adults, and older adults. The end users include hospitals, vaccination clinics, travel clinics, academic and research institutions, and military and government facilities.

Menveo Market Global Report 2026 Market Report bar graph

What Is The Menveo Market Size and Share 2026?

The growth in the historic period can be attributed to expansion of national immunization schedules, historical outbreaks of meningococcal disease, advancements in conjugate vaccine technology, increased awareness of vaccine-preventable diseases, global vaccination initiatives.

What Is The Menveo Market Growth Forecast?

The growth in the forecast period can be attributed to growing investments in vaccine innovation, rising focus on outbreak prevention, expansion of adult and adolescent immunization coverage, increasing travel-related vaccination demand, strengthening of public health infrastructure. Major trends in the forecast period include increasing adoption of conjugate vaccines, rising focus on preventive immunization programs, growing demand for adolescent and travel vaccination, expansion of multivalent vaccine coverage, enhanced emphasis on public health preparedness.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Menveo Market Segmentation

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Are The Drivers Of The Menveo Market?

The increasing prevalence of meningitis is expected to propel the growth of the menveo market going forward. Meningitis is an infection that causes inflammation of the protective membranes surrounding the brain and spinal cord, typically triggered by viral, bacterial, or fungal pathogens. The rise in meningitis prevalence is primarily driven by factors such as increasing global mobility and weakened immune systems, which heighten the risk of disease transmission. Menveo supports public health efforts by providing protection against multiple strains of Neisseria meningitidis, enabling early prevention, reducing disease spread, and lowering the burden of invasive meningococcal infections. For instance, in October 2025, according to the UK Health Security Agency, a UK-based government agency, A total of 378 invasive meningococcal disease (IMD) cases were confirmed in 2024–25. Therefore, the increasing prevalence of meningitis is driving the growth of the menveo industry.

The global expansion of healthcare infrastructure is expected to propel the growth of the menveo going forward. Healthcare infrastructure refers to the physical and organizational structures, facilities, resources, and systems necessary for delivering healthcare services to a population. Several key factors, including the aging global population, the increase in chronic diseases, and technological advancements, drive healthcare infrastructure expansion. Menveo is a meningococcal vaccine that protects patients from invasive meningococcal disease, leveraging healthcare infrastructure through vaccination programs in clinics, hospitals, and public health initiatives. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure increased by 5.6% in nominal terms from 2022 to 2023, marking a significant rise compared to the 0.9% growth seen in 2022. Therefore, the global expansion of healthcare infrastructure is driving the growth of the menveo industry.

Key Players In The Global Menveo Market

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Global Menveo Market Trends and Insights

The key trend in the menveo market is developing innovative vaccine formulations, such as single-vial, fully liquid formulations, to enhance convenience, improve stability, and simplify vaccine administration. Single-vial, fully liquid formulations refer to pharmaceutical products that are pre-mixed and packaged in a single vial, with the active ingredients dissolved in a liquid form, ready for administration. For instance, in November 2024, GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical industry company, received approval from the European Commission (EC) for a new presentation of its meningococcal vaccine, Menveo for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now licensed for use in children aged two years and older, adolescents, and adults. The key features of the approval for the vaccine include its licensing for active immunization in the European Union for children from two years of age, adolescents, and adults, with a new single-vial, fully liquid presentation that eliminates the need for reconstitution before use.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Menveo Market?

The menveo market consists of sales of prefilled syringes, powders for suspension, combination vaccines, booster doses, and single-dose vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Menveo Market Report 2026?

The menveo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the menveo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Menveo Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type of Vaccine, Indication, Age Group, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled GlaxoSmithKline (GSK) Plc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Menveo Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Menveo Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Menveo Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Menveo Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Sustainability, Climate Tech And Circular Economy

4.1.3 Industry 4.0 And Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data And Cybersecurity

4.1.5 Artificial Intelligence And Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Conjugate Vaccines

4.2.2 Rising Focus On Preventive Immunization Programs

4.2.3 Growing Demand For Adolescent And Travel Vaccination

4.2.4 Expansion Of Multivalent Vaccine Coverage

4.2.5 Enhanced Emphasis On Public Health Preparedness

5. Menveo Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Vaccination Clinics

5.3 Travel Clinics

5.4 Academic And Research Institutions

5.5 Military And Government Facilities

6. Menveo Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Menveo Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Menveo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Menveo Market Size, Comparisons And Growth Rate Analysis

7.3. Global Menveo Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Menveo Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Menveo Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Menveo Market Segmentation

9.1. Global Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Conjugate Vaccine, Combination Vaccine

9.2. Global Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

9.3. Global Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infants and Young Children, Adolescents, Adults, Older Adults

9.4. Global Menveo Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

10. Menveo Market Regional And Country Analysis

10.1. Global Menveo Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Menveo Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Menveo Market

11.1. Asia-Pacific Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Menveo Market

12.1. China Menveo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Menveo Market

13.1. India Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Menveo Market

14.1. Japan Menveo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Menveo Market

15.1. Australia Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Menveo Market

16.1. South Korea Menveo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Menveo Market

17.1. Western Europe Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Menveo Market

18.1. UK Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Menveo Market

19.1. Germany Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Menveo Market

20.1. France Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Menveo Market

21.1. Eastern Europe Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Menveo Market

22.1. North America Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Menveo Market

23.1. USA Menveo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Menveo Market

24.1. Canada Menveo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Menveo Market

25.1. South America Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Menveo Market

26.1. Middle East Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Menveo Market

27.1. Africa Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Menveo Market, Segmentation By Type of Vaccine, Segmentation By Indication, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Menveo Market Regulatory and Investment Landscape

29. Menveo Market Competitive Landscape And Company Profiles

29.1. Menveo Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Menveo Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Menveo Market Company Profiles

29.3.1. GlaxoSmithKline (GSK) Plc Overview, Products and Services, Strategy and Financial Analysis

30. Global Menveo Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Menveo Market

32. Menveo Market High Potential Countries, Segments and Strategies

32.1 Menveo Market In 2030 - Countries Offering Most New Opportunities

32.2 Menveo Market In 2030 - Segments Offering Most New Opportunities

32.3 Menveo Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Menveo Market, Overview Of Key Products - Product Examples
  • Table 2: Global Menveo Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Menveo Market, Supply Chain Analysis
  • Table 4: Global Menveo Market, Major Raw Material Providers
  • Table 5: Global Menveo Market, Major Resource Providers
  • Table 6: Global Menveo Market, Major Manufacturers (Suppliers)
  • Table 7: Global Menveo Market, Major Distributors And Channel Partners
  • Table 8: Global Menveo Market, Key Technologies & Future Trends
  • Table 9: Global Menveo Market, Major Trends
  • Table 10: Global Menveo Market, Major End Users
  • Table 11: Global Menveo Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Menveo Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Menveo Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Menveo Market - TAM, US$ Billion, 2025
  • Table 15: Global Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Menveo Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Menveo Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Menveo Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Global Menveo Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 73: Global Menveo Market - Company Scoring Matrix
  • Table 74: GlaxoSmithKline (GSK) Plc Financial Performance
  • Table 75: Global Menveo Market, Competitive Benchmarking (In USD Billions)
  • Table 76: Global Menveo Market, Competitive Dashboard
  • Table 77: Global Menveo Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 78: Global, Menveo Market Size Gain ($ Billion), Segmentation By Type of Vaccine, 2025 – 2030
  • Table 79: Global, Menveo Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 80: Global, Menveo Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

    Figure 1: Global Menveo Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Menveo Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Menveo Market, Supply Chain Analysis
  • Figure 4: Global Menveo Market, Major Raw Material Providers
  • Figure 5: Global Menveo Market, Major Resource Providers
  • Figure 6: Global Menveo Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Menveo Market, Major Distributors And Channel Partners
  • Figure 8: Global Menveo Market, Key Technologies & Future Trends
  • Figure 9: Global Menveo Market, Major Trends
  • Figure 10: Global Menveo Market, Major End Users
  • Figure 11: Global Menveo Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Menveo Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Menveo Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Menveo Market - TAM, US$ Billion, 2025
  • Figure 15: Global Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Menveo Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Menveo Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Menveo Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Menveo Market, Segmentation By Type of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Menveo Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Global Menveo Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 73: Global Menveo Market - Company Scoring Matrix
  • Figure 74: GlaxoSmithKline (GSK) Plc Financial Performance
  • Figure 75: Global Menveo Market, Competitive Benchmarking (In USD Billions)
  • Figure 76: Global Menveo Market, Competitive Dashboard
  • Figure 77: Global Menveo Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 78: Global, Menveo Market Size Gain ($ Billion), Segmentation By Type of Vaccine, 2025 – 2030
  • Figure 79: Global, Menveo Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 80: Global, Menveo Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Frequently Asked Questions

The Menveo market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Menveo market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Menveo market Include, GlaxoSmithKline (GSK) Plc .

Major trend in this market includes: Innovative Vaccine Formulations Driving Market Trends. For further insights on this market. request a sample here

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us